Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ajona

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Current Opinion in Immunology|August 6, 2025
Insights and perspectives into the discovery of complement-related biomarkers in cancerDaniel Ajona, Janire Debersaques, Ruben Pio
Seminars in Immunology|May 28, 2013
Complement inhibition in cancer therapyRuben Pio, Daniel Ajona, John D Lambris
Seminars in Immunology|December 19, 2024
The complement system in clinical oncology: Applications, limitations and challengesDaniel Ajona, Mark S Cragg, Ruben Pio
Seminars in Cell & Developmental Biology|November 21, 2017
Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatmentDaniel Ajona, Sergio Ortiz-Espinosa, Ruben Pio
Methods in Cell Biology|January 25, 2025
A mouse model to assess immunotherapy-related colitisYaiza Senent, Ana Remírez, Beatriz Tavira, et al.
Cancer Letters|September 10, 2022
The complement system as a regulator of tumor-promoting activities mediated by myeloid-derived suppressor cellsYaiza Senent, Beatriz Tavira, Ruben Pio, et al.
Journal of Physiology and Biochemistry|April 8, 2024
Fasting and fasting-mimicking conditions in the cancer immunotherapy eraRuben Pio, Yaiza Senent, Beatriz Tavira, et al.
Frontiers in Immunology|April 20, 2019
Complement in Metastasis: A Comp in the CampDaniel Ajona, Sergio Ortiz-Espinosa, Ruben Pio, et al.
Cancers|August 7, 2021
The Complement System in Ovarian Cancer: An Underexplored Old PathYaiza Senent, Daniel Ajona, Antonio González-Martín, et al.
Molecular Immunology|June 6, 2007
Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactorsMarcin Okroj, Yi-Fan Hsu, Daniel Ajona, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Current Opinion in Immunology|August 6, 2025
Insights and perspectives into the discovery of complement-related biomarkers in cancerDaniel Ajona, Janire Debersaques, Ruben Pio
Seminars in Immunology|May 28, 2013
Complement inhibition in cancer therapyRuben Pio, Daniel Ajona, John D Lambris
Seminars in Immunology|December 19, 2024
The complement system in clinical oncology: Applications, limitations and challengesDaniel Ajona, Mark S Cragg, Ruben Pio
Seminars in Cell & Developmental Biology|November 21, 2017
Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatmentDaniel Ajona, Sergio Ortiz-Espinosa, Ruben Pio
Methods in Cell Biology|January 25, 2025
A mouse model to assess immunotherapy-related colitisYaiza Senent, Ana Remírez, Beatriz Tavira, et al.
Cancer Letters|September 10, 2022
The complement system as a regulator of tumor-promoting activities mediated by myeloid-derived suppressor cellsYaiza Senent, Beatriz Tavira, Ruben Pio, et al.
Journal of Physiology and Biochemistry|April 8, 2024
Fasting and fasting-mimicking conditions in the cancer immunotherapy eraRuben Pio, Yaiza Senent, Beatriz Tavira, et al.
Frontiers in Immunology|April 20, 2019
Complement in Metastasis: A Comp in the CampDaniel Ajona, Sergio Ortiz-Espinosa, Ruben Pio, et al.
Cancers|August 7, 2021
The Complement System in Ovarian Cancer: An Underexplored Old PathYaiza Senent, Daniel Ajona, Antonio González-Martín, et al.
Molecular Immunology|June 6, 2007
Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactorsMarcin Okroj, Yi-Fan Hsu, Daniel Ajona, et al.
Pageof 6